Brinch, C.M.; Hogdall, E.; Junker, N.; Moeller, H.J.; Sandfeld-Paulsen, B.; de Heer, P.; Penninga, L.; Rossen, P.B.; Krarup-Hansen, A.; Aggerholm-Pedersen, N.
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor. Cancers 2022, 14, 5753.
https://doi.org/10.3390/cancers14235753
AMA Style
Brinch CM, Hogdall E, Junker N, Moeller HJ, Sandfeld-Paulsen B, de Heer P, Penninga L, Rossen PB, Krarup-Hansen A, Aggerholm-Pedersen N.
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor. Cancers. 2022; 14(23):5753.
https://doi.org/10.3390/cancers14235753
Chicago/Turabian Style
Brinch, Charlotte Margareta, Estrid Hogdall, Niels Junker, Holger Jon Moeller, Birgitte Sandfeld-Paulsen, Pieter de Heer, Luit Penninga, Philip Blach Rossen, Anders Krarup-Hansen, and Ninna Aggerholm-Pedersen.
2022. "The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor" Cancers 14, no. 23: 5753.
https://doi.org/10.3390/cancers14235753
APA Style
Brinch, C. M., Hogdall, E., Junker, N., Moeller, H. J., Sandfeld-Paulsen, B., de Heer, P., Penninga, L., Rossen, P. B., Krarup-Hansen, A., & Aggerholm-Pedersen, N.
(2022). The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor. Cancers, 14(23), 5753.
https://doi.org/10.3390/cancers14235753
